Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
36 Cards in this Set
- Front
- Back
BPH symptoms
|
symptoms of difficulty starting his urinary stream, worsening nocturia, and a feeling of incomplete emptying of his bladder. Occassionally, he feels the sudden urge to urinate, but has not had incontinence of urine
|
|
PE with BPH?
|
DRE – assess prostate size
Urinalysis – check for WBC, hematuria PSA – baseline and/or rule out cancer Neuro exam – rule out neurogenic bladder US |
|
If you taking metformin, you have
|
HTN and DM
|
|
Assessing prostate size
|
Normal prostate = walnut
Enlarged prostate – described in progressively larger citrus fruits – lime, lemon, orange, grapefruit; more precisely by mL |
|
TX for BPH?
|
-Alpha blockers
Alpha-1 and alpha-2; alpha-2 concentrates in prostate – more specific and less risk for orthostatic hypotension; still cause dizziness. -5-alpha reductase inhibitors Blocks converstion to DNT, suppressing prostate enlargement. Takes up to 2 mos to see results; Side effects = decreased testosterone |
|
Alpha adrenergic blockers in BPH and SE
|
-MOA –
Alpha 1a receptors – 70% concentrated in prostate Alpha 1b receptors – common in vasculature Both non-selective and selective alpha blockers decrease symptoms of BPH by relaxing smooth muscle in the bladder neck -Side effects – Postural hypotension – worse with non-selective blockers; a risk esp in elderly. Dizziness |
|
Alpha adrenergic blockers
-Uroselective |
Tamsulosin
Alfuzosin |
|
Alpha adrenergic blockers
Non-uroselective |
Doxazosin
Terazosin |
|
Alpha adrenergic blockers used with other meds?
|
Use with PDE-5 inhibitors – caution advised; risk of hypotension by potentiation of smooth muscle relaxation in the vasculature
Tamsulosin 0.4mg daily should not cause increased risk of hypotension |
|
5-alpha reductase inhibitors in BPH and SE?
|
MOA – reduce size of the prostate by blocking conversion of testosterone to dihydrotestosterone (DHT); takes 6-12 months to work
Works best in men with larger prostate volumes Side Effects – Ejaculatory dysfunction and decreased libido Theoretical risk of bone loss not evident in studies Works best in concert with alpha adrenergic blockers |
|
Viagra
|
PDE-5 inhibitor
|
|
When would you refer BPH patient to urology for surgical assessment?
|
Meds cease to give relief
If younger than 50 Symptoms of urinary retention PSA > 4ng/mL Develops positive exam findings |
|
PROSTATIC MASSAGE is CONTRAINDICATED, when?
|
ACUTE prostatitis!!
|
|
AP tx for for gonorrhea and chlamydia 33 y/o
|
Rocephin and azithromycin or doxycycline
|
|
AP tx for for gonorrhea and chlamydia 55 y/o
|
Gram negatives – E. Coli, Proteus Mirabilis, Pseudomonas Aeruginosa
Trimethoprim/sulfamethoxazole or fluoroquinolones |
|
How long do you TX? Acute prostatitis
|
4-6 weeks
|
|
Prostatic abscess
Diagnosed by |
CT abd/pelvis if abx do not bring down fever in hospitalized patients
|
|
complications of ABP
|
6 weeks once afebrile
Prostatic abscess Diagnosed on CT abd/pelvis if abx do not bring down fever in hospitalized patients Chronic bacterial prostatitis |
|
chronic prostatitis and 4 glass urine eval
|
Initial void (10 mL – urethral specimen)
Midstream void (10mL – bladder specimen) with culture EPS – prostatic fluid Post prostatic massage void(10mL) |
|
chronic prostatitis TX
|
First line – flouroquinolones;trimethoprim/sulfamethoxazole
4-12 weeks |
|
What is the PSA?
|
Prostate specific antigen,
increases with hypertrophy or cancer (and sometimes infection) of the prostate |
|
“Normal” PSA
|
<4ng/mL- pt don't have prostate; this cutoff detects 70+% of prostate CA
>10 ng/mL has 60% PPV for prostate CA; |
|
free PSA” or unbound PSA
|
increased in benign processes;
free PSA/total PSA <25% when total PSA btwn 4ng/mL and 10ng/mL diagnoses 95% of cancers |
|
what is the cut off age for PSA?
|
Don’t screen over age 75,
|
|
AUA says on PSA
|
screening doesn’t improve outcomes…BUT…if you’re going to screen, you should probably screen men between the ages of 50-75
|
|
USPSTF says on PSA
|
don’t screen anyone, it doesn’t detect clinically significant cancers and make outcomes differences; esp don’t screen men >75
|
|
After a PSA what's next step, slightly elevated PSA with prostate cancer.
|
Refer to urology for transrectal ultrasound and biopsies
|
|
How will you follow the progression of cancer in this patient? What are possible therapies that can be offered that aren’t surgical?
|
Follow PSA
5-alpha reductase inhibitors – can shrink prostate and decrease risk of cancers over long term LHRH antagonists – leuprolide, etc; anti-androgens |
|
Golden number for PSA?
|
10 and >10
|
|
If your patient developed a palpable mass, or PSA went above 10ng/mL what treatment options would be offered, and what is the likelihood of success?
|
Androgen deprivation – LHRH antagonists (luteinizing hormone-releasing hormone) and antiandrogens
Localized radiation or brachytherapy 10 year survival usually 70-80% with low grade non-invasive tumors Prostatectomy – usually transurethral; may be robotic |
|
LAb for Acute prostatitis, UTI, STI (urethritis), Urosepsis
|
PE
ABD; CV; GU; Lab Initial and midstream UA Midstream urine culture Urethral swab or urine sample for N. gonorrhea and C. trachomatis; microscopic exam of urine for trichomonads |
|
patient with acute bacterial prostatitis.
What are the likely organisms? |
Sexually transmitted – N. gonorrhea, C. trachomatis-flaggella tx metranitozol, Trichomonas vaginalis
|
|
list some fluroquinolones
|
Ciprofloxacin
Levofloxacin Moxifloxacin Ofloxacin Norfloxacin Gatifloxacin Gemifloxacin Sparfloxacin Lomefloxacin |
|
TMP/SMX
|
BActrim/Septra
|
|
chronic prostatitis also called
|
chronic pelvic pain
|
|
can shrink prostate and decrease risk of cancers over long term, give what drug?
|
5-alpha reductase inhibitors
|